Norrsken Mind

Norrsken Mind is a foundation focused on enabling research on psychedelic substances and their potential to treat mental health disorders. The organization aims to achieve this through fundraising and grant opportunities.

Their goal is to catalyze more research across Europe to improve the understanding of psychedelic-assisted treatments. They also seek to inform and engage with mental health stakeholders through education and training efforts.

Norrsken Mind is a continuation of Osmond Foundation, which funded the first Swedish modern clinical trial using psilocybin-assisted therapy to treat depression at Karolinska Institutet.

As a player in the Health Care industry, Norrsken Mind's unique focus on psychedelic research positions it at the forefront of a growing field with the potential for significant impact on mental health care.